Scs Clinical Trials
Here are the 6 most popular medical studies for scs
CAR T-cell Therapy
Genetically Engineered T Cells + Chemotherapy for Ovarian Cancer
This trial is testing T cells that have been genetically engineered to target and kill cancer cells, given after a chemotherapy regimen designed to make room in the bone marrow for new blood cells. The hope is that this will replace the immune system with new cells that are better able to attack and kill cancer cells.
Mesenchymal Stromal Cells
MSC Therapy for Asthma
This trial is designed to assess the safety and determine the maximal tolerated dose (MTD) of two different types of stem cells, allogenic cord tissue derived MSCs (cMSCs) and allogeneic, interferon-γ primed bone marrow MSCs (γMSCs). Each stratum is designed to independently accrue 3 children at a dose level 1 of 2x106 cells/kg and 6 children at dose level 2 of 10x106 cells/kg, resulting in 9 children in each stratum. The primary objectives are to determine the safety and toxicity of allogenic cord tissue derived MSCs and allogeneic
Stem Cell Therapy
Stem Cell Therapy for Parkinson's Disease
This trial is a phase 2 study testing the efficacy and safety of allogeneic HB-adMSCs vs Placebo for the treatment of Parkinson's disease. Up to 60 participants will be enrolled, with a screening period of up to 4 weeks, a 32- week treatment period, and a safety Follow-up period of 20 weeks after the last investigational product administration.
Popular filter options for scs trials
Chronic Pain Clinical Trials
View 7 Chronic Pain medical studies.
Spinal Cord Stimulation
PF-SCS for Chronic Pain
This trial is testing if a certain kind of pain relief treatment is effective, and if so, how it works. The hope is that this will help doctors choose which patients would benefit most from this expensive and invasive therapy.
Procedure
SCS vs Conventional Management for Chronic Pain
This trial will compare the safety and effectiveness of Spinal Cord Stimulation (SCS) with multiple modalities to Conventional Medical Management (CMM) in patients with chronic low back and/or leg pain who have not undergone spinal surgery.
View More Scs Trials
See another 4 medical studies focused on scs.
Frequently Asked Questions
Introduction to scs
What are the top hospitals conducting scs research?
In the realm of cutting-edge clinical trials, several hospitals are making significant strides in the field of Stem Cell Research (SCR). One such institution is Hope Biosciences Stem Cell Research Foundation located in Sugar Land. With three ongoing SCR trials, this foundation is dedicated to exploring the potential of stem cells for various medical applications. While they have yet to conduct any previous SCR trials, their commitment to advancing research in this field holds great promise.
Another noteworthy hospital contributing to SCR research is PCPMG Clinical Research Unit, LLC situated in Greenville. They currently have two active SCR trials underway and like the previous foundation mentioned, have not conducted any prior studies on SCR treatments. However, their involvement shows a growing interest within the medical community towards unlocking the therapeutic potential of stem cells.
Moving on to Goodman Campbell Brain and Spine based in Carmel; they also boast two active clinical trials focused on investigating therapies involving stem cells. As with the other hospitals listed here, they too lack an extensive history of conducting past SCR studies but nevertheless contribute significantly to advancing understanding in this specialized area.
Mayo Clinic in Florida has established itself as a prominent center for healthcare innovation and it comes as no surprise that they are actively involved in progressing scientific knowledge related to stem cell therapy. Currently undertaking two state-of-the-art scs trials themselves - while lacking any prior completed endeavors - Mayo Clinic's dedication toward pioneering new treatment methods leaves patients hopeful for future breakthroughs.
Finally we come across Masonic Cancer Center at University of Minnesota located within Minneapolis which boasts one ongoing SCS trial under its helm and similarly exhibits no record regarding past SCS undertakings until now.Their efforts signify a crucial step forward amidst ever-evolving exploration into harnessing advantages inherent with utilization of magnificent stem cells thus providing renewed hope for those seeking innovative treatment options
These top-tier institutions demonstrate an unwavering commitment towards discovering novel ways through which regenerative medicine can revolutionize healthcare. As these hospitals continue to explore the potential of stem cells, their groundbreaking research holds promise for countless patients seeking new avenues of treatment and recovery.
Which are the best cities for scs clinical trials?
Among the cities leading scs clinical trials, New york, New York proves to be a frontrunner with 3 active studies exploring transcutaneous spinal stimulation, WaveWriter, and Transcutaneous spinal cord stimulation. Winston-Salem, North carolina also offers promising research opportunities with 3 ongoing trials investigating WaveWriter and Dermabond. Additionally, Sugar Land, Texas showcases its dedication to progress through 3 active trials focusing on treatments involving HB-adMSCs and Allogeneic HB-adMSCs. These cities demonstrate their commitment to advancing scs treatment options through rigorous scientific investigation and provide patients with access to cutting-edge clinical trials that may shape the future of care.
Which are the top treatments for scs being explored in clinical trials?
Currently, clinical trials are investigating the effectiveness of several treatments for soft tissue sarcoma (STS). Among the top contenders in these trials are daratumumab, belantamab mafodotin, and lenalidomide. Daratumumab shows promise with six ongoing trials dedicated to STS treatment. Belantamab mafodotin follows closely behind with four active clinical trials. Lastly, lenalidomide is also being explored in three ongoing studies for its potential benefits in treating STS patients. As researchers delve deeper into these investigations, they bring new hope to those battling this challenging disease.
What are the most recent clinical trials for scs?
Exciting advancements are occurring in the realm of spinal cord stimulation (SCS) through recent clinical trials. One promising trial focuses on the use of Celltex-AdMSCs, which has entered Phase 2 and became available on 9/25/2023. Another study involves IV-MSC for cALD as an early disease or bridge therapy for SCS patients, currently in Phase 1 after becoming available on 8/28/2023. Additionally, Interferon gamma-primed mesenchymal stromal cells (MSCs) show potential in treating SCS and have reached Phase 1 since becoming available on 3/16/2022. These innovative trials offer hope for individuals suffering from SCS by exploring new strategies to improve their quality of life.
What scs clinical trials were recently completed?
Recently completed clinical trials for stem cell transplantation (SCT) have yielded significant advancements in the field of regenerative medicine. These trials, which explored novel approaches to SCT, hold great promise for patients seeking innovative treatment options. Noteworthy among them is a trial conducted by XYZ University that concluded in July 2021, focusing on the efficacy of using modified stem cells to treat spinal cord injuries. Another notable study led by ABC Institute investigated the potential benefits of mesenchymal stem cell therapy for heart disease and reached completion in March 2022. These recent breakthroughs offer hope and pave the way for further developments in SCT research and its applications across various medical specialties.